Nalmefene (trade name Selincro) originally known as nalmetrene is an opioid receptor antagonist developed in the early 1970s and used primarily in the management of alcohol dependence and also has been investigated for the treatment of other addictions such as pathological gambling and addiction to shopping.Nalmefene is an opiate derivative similar in both structure and activity to the opiate antagonist naltrexone.
This page contains content from the copyrighted Wikipedia article "Nalmefene"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
